{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:29:04Z","timestamp":1792301344863,"version":"4.4.0"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T00:00:00Z","timestamp":1624060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.nano.2021.102433","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T06:46:50Z","timestamp":1624517210000},"page":"102433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases"],"prefix":"10.1016","volume":"36","author":[{"given":"Nour K.","family":"Younis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Ghoubaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel P.","family":"Bassil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda N.","family":"Tantawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2021.102433_bb0005","series-title":"Cardiovascular diseases (CVDs)","author":"WHO","year":"2019"},{"key":"10.1016\/j.nano.2021.102433_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/CIRCULATIONAHA.115.014849","article-title":"Primordial prevention of cardiovascular disease","volume":"131","author":"Gillman","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.nano.2021.102433_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jacc.2014.10.024","article-title":"Healthy lifestyle in the primordial prevention of cardiovascular disease among young women","volume":"65","author":"Chomistek","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nano.2021.102433_bb0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2021.102433_bb0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.106.179294","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"115","author":"Buse","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.nano.2021.102433_bb0030","unstructured":"Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed). 2016; 69: 939."},{"key":"10.1016\/j.nano.2021.102433_bb0035","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/hrt.2003.027680","article-title":"Cardiovascular disease: different strategies for primary and secondary prevention?","volume":"90","author":"Hobbs","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.nano.2021.102433_bb0040","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.2337\/dc18-S009","article-title":"9. Cardiovascular disease and risk management: standards of medical care in diabetes\u20142018","volume":"41","author":"American","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nano.2021.102433_bb0045","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2021.102433_bb0050","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Vandvik","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.nano.2021.102433_bb0055","doi-asserted-by":"crossref","unstructured":"Taylor F, Ward K, Moore TH, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2011: CD004816.","DOI":"10.1002\/14651858.CD004816.pub4"},{"key":"10.1016\/j.nano.2021.102433_bb0060","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/CIRCULATIONAHA.114.014209","article-title":"Efficacy of long-term beta-blocker therapy for secondary prevention of long-term outcomes after coronary artery bypass grafting surgery","volume":"131","author":"Zhang","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.nano.2021.102433_bb0065","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1185\/030079904X4185","article-title":"Provision of cardiovascular protection by ACE inhibitors: a review of recent trials","volume":"20","author":"Bertrand","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nano.2021.102433_bb0070","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.ymthe.2017.03.027","article-title":"Cardiovascular gene therapy: past, present, and future","volume":"25","author":"Yla-Herttuala","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2021.102433_bb0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/cvr\/cvv205","article-title":"Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation","volume":"108","author":"Rincon","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nano.2021.102433_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000119","article-title":"Gene therapy to treat cardiovascular disease","volume":"2","author":"Wolfram","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nano.2021.102433_bb0085","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/CIRCRESAHA.111.252981","article-title":"Gene therapy for heart failure","volume":"110","author":"Tilemann","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.nano.2021.102433_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI62837","article-title":"Potential of gene therapy as a treatment for heart failure","volume":"123","author":"Hajjar","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2021.102433_bb0095","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2015.61","article-title":"Gene therapy to treat cardiac arrhythmias","volume":"12","author":"Bongianino","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nano.2021.102433_bb0100","doi-asserted-by":"crossref","first-page":"9640108","DOI":"10.1155\/2017\/9640108","article-title":"Cellular therapeutics for heart failure: focus on mesenchymal stem cells","volume":"2017","author":"Pandey","year":"2017","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.nano.2021.102433_bb0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3727\/096368914X678436","article-title":"Mesenchymal stem cell insights: prospects in cardiovascular therapy","volume":"23","author":"Chou","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.nano.2021.102433_bb0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration \u2014 lessons learned and future directions","volume":"15","author":"Menasche","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nano.2021.102433_bb0115","doi-asserted-by":"crossref","unstructured":"Clifford DM, Fisher SA, Brunskill SJ, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012: CD006536.","DOI":"10.1002\/14651858.CD006536.pub3"},{"key":"10.1016\/j.nano.2021.102433_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1753944717692293","article-title":"Nanomedicine applied to cardiovascular diseases: latest developments","volume":"11","author":"Martin Gimenez","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.nano.2021.102433_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fcvm.2017.00087","article-title":"Anti-inflammatory nanomedicine for cardiovascular disease","volume":"4","author":"Katsuki","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.nano.2021.102433_bb0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd3578","article-title":"Perspectives and opportunities for nanomedicine in the management of atherosclerosis","volume":"10","author":"Lobatto","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nano.2021.102433_bb0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2217\/nnm.16.3","article-title":"Nanotechnology in diagnosis and treatment of coronary artery disease","volume":"11","author":"Karimi","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2021.102433_bb0140","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00204-014-1447-8","article-title":"Role of silver nanoparticles (AgNPs) on the cardiovascular system","volume":"90","author":"Gonzalez","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0145","first-page":"2399","article-title":"Nanosilver particles in medical applications: synthesis, performance, and toxicity","volume":"9","author":"Ge","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0150","doi-asserted-by":"crossref","first-page":"4940397","DOI":"10.1155\/2017\/4940397","article-title":"Nanotechnology-based cardiac targeting and direct cardiac reprogramming: the betrothed","volume":"2017","author":"Passaro","year":"2017","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.nano.2021.102433_bb0155","doi-asserted-by":"crossref","first-page":"1384658","DOI":"10.1155\/2016\/1384658","article-title":"Nanoparticles-assisted stem cell therapy for ischemic heart disease","volume":"2016","author":"Zhu","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.nano.2021.102433_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1470","article-title":"Gold nanoparticles in cardiovascular imaging","volume":"10","author":"Varna","year":"2018","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2021.102433_bb0165","doi-asserted-by":"crossref","unstructured":"Mulder WJ, Jaffer FA, Fayad ZA and Nahrendorf M. Imaging and nanomedicine in inflammatory atherosclerosis. Sci Transl Med. 2014; 6: 239sr1.","DOI":"10.1126\/scitranslmed.3005101"},{"key":"10.1016\/j.nano.2021.102433_bb0170","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2217\/nnm.16.6","article-title":"Nanoparticle drug delivery systems and their use in cardiac tissue therapy","volume":"11","author":"Ho","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2021.102433_bb0175","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nano.2021.102433_bb0180","first-page":"105","article-title":"The role of nanotechnology in the treatment of viral infections","volume":"4","author":"Singh","year":"2017","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.nano.2021.102433_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40199-015-0125-6","article-title":"Nanoparticles as potential new generation broad spectrum antimicrobial agents","volume":"23","author":"Yah","year":"2015","journal-title":"Daru"},{"key":"10.1016\/j.nano.2021.102433_bb0190","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.3390\/molecules16108894","article-title":"Silver nanoparticles as potential antiviral agents","volume":"16","author":"Galdiero","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.nano.2021.102433_bb0195","doi-asserted-by":"crossref","DOI":"10.4178\/epih\/e2015020","article-title":"Antimicrobial properties of nanomolecules: potential candidates as antibiotics in the era of multi-drug resistance","volume":"37","author":"Kandi","year":"2015","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.nano.2021.102433_bb0200","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2013.04.022","article-title":"Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction","volume":"170","author":"Chang","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2021.102433_bb0205","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.biopha.2017.07.012","article-title":"Magnetic iron oxide nanoparticles as novel and efficient tools for atherosclerosis diagnosis","volume":"93","author":"Montiel Schneider","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2021.102433_bb0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2014.08.002","article-title":"Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications","volume":"18","author":"Jin","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.nano.2021.102433_bb0215","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nantod.2011.10.001","article-title":"Toxicology and clinical potential of nanoparticles","volume":"6","author":"Yildirimer","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2021.102433_bb0220","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.addr.2012.08.005","article-title":"Interactions of nanomaterials and biological systems: implications to personalized nanomedicine","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2021.102433_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.nano.2021.102433_bb0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/1871529X18666180508113253","article-title":"Nanoparticle based treatment for cardiovascular diseases","volume":"19","author":"Gupta","year":"2019","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.nano.2021.102433_bb0235","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3389\/fbioe.2020.00687","article-title":"Nanoparticle-mediated drug delivery for treatment of ischemic heart disease","volume":"8","author":"Fan","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nano.2021.102433_bb0240","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2021.102433_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1416","article-title":"Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials","volume":"9","author":"Caster","year":"2017","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2021.102433_bb0250","first-page":"742","article-title":"Progress in nanomedicine: approved and investigational nanodrugs","volume":"42","author":"Ventola","year":"2017","journal-title":"P T"},{"key":"10.1016\/j.nano.2021.102433_bb0255","first-page":"345","article-title":"Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi\u2019s sarcoma","volume":"2","author":"Udhrain","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0260","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1634\/theoncologist.12-1-114","article-title":"A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi\u2019s sarcoma","volume":"12","author":"Cooley","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.nano.2021.102433_bb0265","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMra0912273","article-title":"Nanomedicine","volume":"363","author":"Kim","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2021.102433_bb0270","doi-asserted-by":"crossref","first-page":"12425","DOI":"10.1021\/acsnano.5b05783","article-title":"Parallel comparative studies on mouse toxicity of oxide nanoparticle- and gadolinium-based T1 MRI contrast agents","volume":"9","author":"Chen","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2021.102433_bb0275","first-page":"1727","article-title":"Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents","volume":"10","author":"Estelrich","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0280","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1681\/ASN.2007101156","article-title":"Ferumoxytol for treating iron deficiency anemia in CKD","volume":"19","author":"Spinowitz","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nano.2021.102433_bb0285","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2165\/11209880-000000000-00000","article-title":"Ferumoxytol: in iron deficiency anaemia in adults with chronic kidney disease","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2021.102433_bb0290","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCIMAGING.112.978932","article-title":"Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction","volume":"5","author":"Sosnovik","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nano.2021.102433_bb0295","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/nn900440e","article-title":"Small multifunctional nanoclusters (nanoroses) for targeted cellular imaging and therapy","volume":"3","author":"Ma","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2021.102433_bb0300","doi-asserted-by":"crossref","unstructured":"Jasmin, de Souza GT, Louzada RA, Rosado-de-Castro PH, Mendez-Otero R and Campos de Carvalho AC. Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. Int J Nanomedicine. 2017; 12: 779\u201393.","DOI":"10.2147\/IJN.S126530"},{"key":"10.1016\/j.nano.2021.102433_bb0305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jmri.21263","article-title":"Stem cell therapy: MRI guidance and monitoring","volume":"27","author":"Kraitchman","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.nano.2021.102433_bb0310","doi-asserted-by":"crossref","first-page":"4198790","DOI":"10.1155\/2016\/4198790","article-title":"Magnetic nanoparticles for targeting and imaging of stem cells in myocardial infarction","volume":"2016","author":"Santoso","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.nano.2021.102433_bb0315","doi-asserted-by":"crossref","first-page":"17135","DOI":"10.1038\/srep17135","article-title":"Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI","volume":"5","author":"Tarin","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2021.102433_bb0320","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s13346-018-0567-8","article-title":"The effects of superparamagnetic iron oxide nanoparticles-labeled mesenchymal stem cells in the presence of a magnetic field on attenuation of injury after heart failure","volume":"8","author":"Naseroleslami","year":"2018","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.nano.2021.102433_bb0325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2015.09.002","article-title":"Integration of mesenchymal stem cells with nanobiomaterials for the repair of myocardial infarction","volume":"95","author":"Han","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2021.102433_bb0330","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","article-title":"Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications","volume":"138","author":"Dadfar","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2021.102433_bb0335","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fimmu.2014.00579","article-title":"Dynamic aspects of macrophage polarization during atherosclerosis progression and regression","volume":"5","author":"Peled","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2021.102433_bb0340","doi-asserted-by":"crossref","first-page":"21526","DOI":"10.18632\/oncotarget.15630","article-title":"CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.nano.2021.102433_bb0345","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fimmu.2016.00275","article-title":"M1- and M2-type macrophage responses are predictive of adverse outcomes in human atherosclerosis","volume":"7","author":"de Gaetano","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2021.102433_bb0350","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrcardio.2014.173","article-title":"Macrophage subsets in atherosclerosis","volume":"12","author":"Chinetti-Gbaguidi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.nano.2021.102433_bb0355","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/CIRCRESAHA.114.301174","article-title":"Mechanisms that regulate macrophage burden in atherosclerosis","volume":"114","author":"Randolph","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.nano.2021.102433_bb0360","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2021.102433_bb0365","doi-asserted-by":"crossref","first-page":"693083","DOI":"10.1155\/2012\/693083","article-title":"Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery","volume":"2012","author":"Gui","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.nano.2021.102433_bb0370","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2147\/IJN.S184920","article-title":"Iron oxide nanoparticles promote the migration of mesenchymal stem cells to injury sites","volume":"14","author":"Li","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0375","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/scrt360","article-title":"Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction","volume":"4","author":"Huang","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.nano.2021.102433_bb0380","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1016\/j.biomaterials.2014.06.031","article-title":"Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction","volume":"35","author":"Vandergriff","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102433_bb0385","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biomaterials.2017.11.012","article-title":"Improved heart repair upon myocardial infarction: combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes","volume":"155","author":"Ottersbach","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102433_bb0390","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jcmm.13331","article-title":"Systemic redistribution of the intramyocardially injected mesenchymal stem cells by repeated remote ischaemic post-conditioning","volume":"22","author":"Jiang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.nano.2021.102433_bb0395","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.yjmcc.2006.07.023","article-title":"Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction","volume":"41","author":"Muller-Ehmsen","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nano.2021.102433_bb0400","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nano.2017.09.004","article-title":"Uptake and bioreactivity of charged chitosan-coated superparamagnetic nanoparticles as promising contrast agents for magnetic resonance imaging","volume":"14","author":"Kania","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0405","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1038\/srep08579","article-title":"Cardioprotective activity of iron oxide nanoparticles","volume":"5","author":"Xiong","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2021.102433_bb0410","doi-asserted-by":"crossref","first-page":"72586","DOI":"10.1039\/C6RA10994B","article-title":"Novel nanostructural contrast for magnetic resonance imaging of endothelial inflammation: targeting SPIONs to vascular endothelium","volume":"6","author":"Kaczy\u0144ska","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.nano.2021.102433_bb0415","unstructured":"Vazquez-Prada KX, Lam J, Kamato D, Ping Xu Z, Little PJ and Ta HT. Targeted molecular imaging of cardiovascular diseases by iron oxide nanoparticles. Arterioscler Thromb Vasc Biol. 2020: ATVBAHA120315404."},{"key":"10.1016\/j.nano.2021.102433_bb0420","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41551-020-00637-1","article-title":"Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles","volume":"4","author":"Liu","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.nano.2021.102433_bb0425","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biomaterials.2017.04.037","article-title":"Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast","volume":"134","author":"Ta","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102433_bb0430","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/mmr.2014.2649","article-title":"In vivo magnetic resonance imaging tracking of transplanted superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells in rats with myocardial infarction","volume":"11","author":"Hua","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.nano.2021.102433_bb0435","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/CIRCIMAGING.110.959866","article-title":"Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study","volume":"4","author":"Richards","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"issue":"Suppl 1","key":"10.1016\/j.nano.2021.102433_bb0440","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10554-008-9407-0","article-title":"In vivo magnetic resonance imaging of injected mesenchymal stem cells in rat myocardial infarction; simultaneous cell tracking and left ventricular function measurement","volume":"25","author":"Kim","year":"2009","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.nano.2021.102433_bb0445","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/01.CIR.0000070931.62772.4E","article-title":"In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction","volume":"107","author":"Kraitchman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.nano.2021.102433_bb0450","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2217\/nnm.14.169","article-title":"Gold nanoparticles for photoacoustic imaging","volume":"10","author":"Li","year":"2015","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2021.102433_bb0455","doi-asserted-by":"crossref","unstructured":"Cole LE, Ross RD, Tilley JM, Vargo-Gogola T and Roeder RK. Gold nanoparticles as contrast agents in x-ray imaging and computed tomography. Nanomedicine (Lond). 2015; 10: 321\u201341.","DOI":"10.2217\/nnm.14.171"},{"key":"10.1016\/j.nano.2021.102433_bb0460","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cmmi.1551","article-title":"Nanoparticle contrast agents for computed tomography: a focus on micelles","volume":"9","author":"Cormode","year":"2014","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.nano.2021.102433_bb0465","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2174\/1568026615666150414144750","article-title":"Biomedical applications of gold nanoparticles","volume":"15","author":"Cabuzu","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.nano.2021.102433_bb0470","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4155\/tde.12.21","article-title":"Size matters: gold nanoparticles in targeted cancer drug delivery","volume":"3","author":"Dreaden","year":"2012","journal-title":"Ther Deliv"},{"key":"10.1016\/j.nano.2021.102433_bb0475","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/NSA.S3788","article-title":"Applications of gold nanoparticles in cancer nanotechnology","volume":"1","author":"Cai","year":"2008","journal-title":"Nanotechnol Sci Appl"},{"key":"10.1016\/j.nano.2021.102433_bb0480","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1259\/bjr\/59448833","article-title":"Gold nanoparticles as novel agents for cancer therapy","volume":"85","author":"Jain","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.nano.2021.102433_bb0485","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.2217\/nnm-2018-0264","article-title":"Nanoparticles for postinfarct ventricular remodeling","volume":"13","author":"Dong","year":"2018","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2021.102433_bb0490","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.molmed.2010.10.006","article-title":"Nanotechnology for synthetic high-density lipoproteins","volume":"16","author":"Luthi","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nano.2021.102433_bb0495","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1096\/fj.10-171728","article-title":"Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons","volume":"25","author":"Pan","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.nano.2021.102433_bb0500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cmmi.1491","article-title":"VCAM-1-targeting gold nanoshell probe for photoacoustic imaging of atherosclerotic plaque in mice","volume":"8","author":"Rouleau","year":"2013","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.nano.2021.102433_bb0505","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1021\/ac3006445","article-title":"Detection of inflammation in vivo by surface-enhanced Raman scattering provides higher sensitivity than conventional fluorescence imaging","volume":"84","author":"McQueenie","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.nano.2021.102433_bb0510","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.nano.2013.03.009","article-title":"CT imaging of myocardial scars with collagen-targeting gold nanoparticles","volume":"9","author":"Danila","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0515","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.2147\/IJN.S130951","article-title":"PEG-coated gold nanoparticles attenuate beta-adrenergic receptor-mediated cardiac hypertrophy","volume":"12","author":"Qiao","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0520","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.nano.2021.102433_bb0525","doi-asserted-by":"crossref","first-page":"f55","DOI":"10.1136\/bmj.f55","article-title":"Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis","volume":"346","author":"Chatterjee","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.nano.2021.102433_bb0530","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/01.CIR.0000065187.80707.18","article-title":"Beta-blockers in chronic heart failure","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.nano.2021.102433_bb0535","doi-asserted-by":"crossref","first-page":"12854","DOI":"10.1021\/acsnano.0c03629","article-title":"Gold nanorod-based nanoplatform catalyzes constant NO generation and protects from cardiovascular injury","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2021.102433_bb0540","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jconrel.2020.11.002","article-title":"Light-induced release of the cardioprotective peptide angiotensin-(1-9) from thermosensitive liposomes with gold nanoclusters","volume":"328","author":"Bejarano","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2021.102433_bb0545","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biomaterials.2016.02.009","article-title":"Labeling monocytes with gold nanoparticles to track their recruitment in atherosclerosis with computed tomography","volume":"87","author":"Chhour","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102433_bb0550","doi-asserted-by":"crossref","first-page":"10398","DOI":"10.1021\/la301694q","article-title":"Syntheses and characterization of lisinopril-coated gold nanoparticles as highly stable targeted CT contrast agents in cardiovascular diseases","volume":"28","author":"Ghann","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.nano.2021.102433_bb0555","doi-asserted-by":"crossref","first-page":"106016","DOI":"10.1117\/1.JBO.17.10.106016","article-title":"Intravascular photoacoustic imaging of exogenously labeled atherosclerotic plaque through luminal blood","volume":"17","author":"Yeager","year":"2012","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.nano.2021.102433_bb0560","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1148\/radiol.10092473","article-title":"Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles","volume":"256","author":"Cormode","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.nano.2021.102433_bb0565","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1021\/nl801852e","article-title":"Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques","volume":"9","author":"Wang","year":"2009","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2021.102433_bb0570","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.2147\/IJN.S83953","article-title":"Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by Bacillus tequilensis and Calocybe indica in MDA-MB-231 human breast cancer cells: targeting p53 for anticancer therapy","volume":"10","author":"Gurunathan","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0575","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00253-009-2159-5","article-title":"Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli","volume":"85","author":"Li","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.nano.2021.102433_bb0580","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/nl0155274","article-title":"Fungus-mediated synthesis of silver nanoparticles and their immobilization in the mycelial matrix: a novel biological approach to nanoparticle synthesis","volume":"1","author":"Mukherjee","year":"2001","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2021.102433_bb0585","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091534","article-title":"Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches","volume":"17","author":"Zhang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2021.102433_bb0590","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nano.2008.04.005","article-title":"The antimicrobial sensitivity of Streptococcus mutans to nanoparticles of silver, zinc oxide, and gold","volume":"4","author":"Hernandez-Sierra","year":"2008","journal-title":"Nanomedicine\u202f: nanotechnology, biology, and medicine"},{"key":"10.1016\/j.nano.2021.102433_bb0595","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tibtech.2010.07.006","article-title":"Nanosilver as a new generation of nanoproduct in biomedical applications","volume":"28","author":"Chaloupka","year":"2010","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2021.102433_bb0600","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1039\/C2CS35392J","article-title":"Nanotoxicity assessment of quantum dots: from cellular to primate studies","volume":"42","author":"Yong","year":"2013","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2021.102433_bb0605","article-title":"Silver nanoparticles: synthesis and application for Nanomedicine","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2021.102433_bb0610","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3390\/microorganisms8091400","article-title":"Antibacterial activity of silver and its application in dentistry","volume":"8","author":"Talapko","year":"2020","journal-title":"Cardiology and Dermatology Microorganisms"},{"key":"10.1016\/j.nano.2021.102433_bb0615","first-page":"51","article-title":"Ram Kumar Pandian S, et al","volume":"73","author":"Kalishwaralal","year":"2009","journal-title":"Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2021.102433_bb0620","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/nn400594s","article-title":"Silver nanoparticles induced RNA polymerase-silver binding and RNA transcription inhibition in erythroid progenitor cells","volume":"7","author":"Wang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2021.102433_bb0625","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3109\/17435390.2014.980449","article-title":"Endothelial cell activation, oxidative stress and inflammation induced by a panel of metal-based nanomaterials","volume":"9","author":"Danielsen","year":"2015","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2021.102433_bb0630","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.1016\/j.biomaterials.2014.04.093","article-title":"Endothelial cell injury and dysfunction induced by silver nanoparticles through oxidative stress via IKK\/NF-kappaB pathways","volume":"35","author":"Shi","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102433_bb0635","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1021\/nn800596w","article-title":"Low Kah Mun G, Hande MP and Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells","volume":"3","author":"AshaRani","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2021.102433_bb0640","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1016\/j.biomaterials.2013.07.015","article-title":"Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions","volume":"34","author":"Guo","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102433_bb0645","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1016\/j.biomaterials.2009.08.008","article-title":"Antiangiogenic properties of silver nanoparticles","volume":"30","author":"Gurunathan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2021.102433_bb0650","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(01)00923-1","article-title":"Characterization of nanoparticle uptake by endothelial cells","volume":"233","author":"Davda","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2021.102433_bb0655","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and inflammatory mechanisms of atherosclerosis (*)","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nano.2021.102433_bb0660","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","article-title":"Adhesion molecules and atherosclerosis","volume":"170","author":"Blankenberg","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nano.2021.102433_bb0665","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","article-title":"Vascular adhesion molecules in atherosclerosis","volume":"27","author":"Galkina","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nano.2021.102433_bb0670","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/jat.3315","article-title":"Silver nanoparticles induce pro-inflammatory gene expression and inflammasome activation in human monocytes","volume":"36","author":"Murphy","year":"2016","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0675","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2017.10.027","article-title":"NLRP3 inflammasome pathways in atherosclerosis","volume":"267","author":"Baldrighi","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nano.2021.102433_bb0680","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/er.2001-0037","article-title":"The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues","volume":"24","author":"Rigotti","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.nano.2021.102433_bb0685","article-title":"Implications of scavenger receptors in the safe development of nanotherapeutics","volume":"2","author":"Shannahan","year":"2015","journal-title":"Receptors Clin Investig"},{"key":"10.1016\/j.nano.2021.102433_bb0690","doi-asserted-by":"crossref","unstructured":"Wang H, Wu L and Reinhard BM. Scavenger receptor mediated endocytosis of silver nanoparticles into J774A.1 macrophages is heterogeneous. ACS nano. 2012; 6: 7122\u201332.","DOI":"10.1021\/nn302186n"},{"key":"10.1016\/j.nano.2021.102433_bb0695","doi-asserted-by":"crossref","first-page":"12610","DOI":"10.1073\/pnas.94.23.12610","article-title":"A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism","volume":"94","author":"Rigotti","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2021.102433_bb0700","doi-asserted-by":"crossref","first-page":"127235","DOI":"10.1155\/2015\/127235","article-title":"Impact of silver and iron nanoparticle exposure on cholesterol uptake by macrophages","volume":"2015","author":"Shannahan","year":"2015","journal-title":"Journal of Nanomaterials"},{"key":"10.1016\/j.nano.2021.102433_bb0705","first-page":"827","article-title":"The acute toxic effects of silver nanoparticles on myocardial transmembrane potential, INa and IK1 channels and heart rhythm in mice","volume":"11","author":"Lin","year":"2017","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2021.102433_bb0710","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/17435390.2014.992815","article-title":"Effects of acute systemic administration of TiO2, ZnO, SiO2, and Ag nanoparticles on hemodynamics, hemostasis and leukocyte recruitment","volume":"9","author":"Haberl","year":"2015","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2021.102433_bb0715","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nano.2017.11.013","article-title":"Evaluation of cardiovascular responses to silver nanoparticles (AgNPs) in spontaneously hypertensive rats","volume":"14","author":"Ramirez-Lee","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0720","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-8977-11-11","article-title":"Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release","volume":"11","author":"Gliga","year":"2014","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119726","article-title":"Pulmonary toxicity of instilled silver nanoparticles: influence of size, coating and rat strain","volume":"10","author":"Seiffert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2021.102433_bb0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2017.08.011","article-title":"Gold nanoparticles: distribution, bioaccumulation and toxicity. In vitro and in vivo studies","volume":"14","author":"Lopez-Chaves","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0735","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00204-017-2016-8","article-title":"Toxic effects and biodistribution of ultrasmall gold nanoparticles","volume":"91","author":"Schmid","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0740","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.actbio.2017.01.082","article-title":"Cytotoxicity of gold nanoparticles with different structures and surface-anchored chiral polymers","volume":"53","author":"Deng","year":"2017","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2021.102433_bb0745","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s10856-017-5902-y","article-title":"Size and shape-dependent cytotoxicity profile of gold nanoparticles for biomedical applications","volume":"28","author":"Wozniak","year":"2017","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.nano.2021.102433_bb0750","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.fct.2017.11.051","article-title":"Stable PEG-coated silver nanoparticles \u2014 a comprehensive toxicological profile","volume":"111","author":"Pinzaru","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0755","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00775-017-1468-x","article-title":"Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study","volume":"22","author":"Das","year":"2017","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.nano.2021.102433_bb0760","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/17435390.2017.1314036","article-title":"Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells","volume":"11","author":"Chandran","year":"2017","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2021.102433_bb0765","first-page":"310","article-title":"Self-assembly of bacitracin-gold nanoparticles and their toxicity analysis","volume":"82","author":"Li","year":"2018","journal-title":"Korean J Couns Psychother"},{"key":"10.1016\/j.nano.2021.102433_bb0770","doi-asserted-by":"crossref","first-page":"17911","DOI":"10.1039\/C5DT02118A","article-title":"The cytotoxicity of gold nanoparticles is dispersity-dependent","volume":"44","author":"Huang","year":"2015","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nano.2021.102433_bb0775","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.etp.2014.09.005","article-title":"Evaluation of hepatotoxic and genotoxic potential of silver nanoparticles in albino rats","volume":"67","author":"El Mahdy","year":"2015","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.nano.2021.102433_bb0780","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3390\/ijerph120201112","article-title":"The biomechanisms of metal and metal-oxide nanoparticles\u2019 interactions with cells","volume":"12","author":"Teske","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.nano.2021.102433_bb0785","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-8977-11-11","article-title":"Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release","volume":"11","author":"Gliga","year":"2014","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0790","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.fct.2017.11.051","article-title":"Stable PEG-coated silver nanoparticles \u2014 a comprehensive toxicological profile","volume":"111","author":"Pinzaru","year":"2018","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0795","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.etp.2014.09.005","article-title":"Evaluation of hepatotoxic and genotoxic potential of silver nanoparticles in albino rats","volume":"67","author":"El Mahdy","year":"2015","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.nano.2021.102433_bb0800","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1166\/jnn.2016.10728","article-title":"In vitro uptake of silver nanoparticles and their toxicity in human mesenchymal stem cells derived from bone marrow","volume":"16","author":"He","year":"2016","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.nano.2021.102433_bb0805","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00204-016-1730-y","article-title":"Differential genotoxicity mechanisms of silver nanoparticles and silver ions","volume":"91","author":"Li","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0810","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.taap.2019.01.006","article-title":"Pulmonary exposure to silver nanoparticles impairs cardiovascular homeostasis: effects of coating, dose and time","volume":"367","author":"Ferdous","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.nano.2021.102433_bb0815","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.lfs.2018.09.001","article-title":"Toxicity of silver nanoparticles on different tissues of Balb\/C mice","volume":"211","author":"Moradi-Sardareh","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.nano.2021.102433_bb0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185554","article-title":"Acute toxicity and genotoxicity of silver nanoparticle in rats","volume":"12","author":"Wen","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.nano.2021.102433_bb0825","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yrtph.2018.08.007","article-title":"Toxicity of silver ions, metallic silver, and silver nanoparticle materials after in vivo dermal and mucosal surface exposure: a review","volume":"98","author":"Hadrup","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.nano.2021.102433_bb0830","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/17435390.2016.1189614","article-title":"Mechanisms of silver nanoparticle-induced toxicity and important role of autophagy","volume":"10","author":"Mao","year":"2016","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2021.102433_bb0835","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.nano.2017.05.015","article-title":"Human brain endothelial barrier cells are distinctly less vulnerable to silver nanoparticles toxicity than human blood vessel cells: a cell-specific mechanism of the brain barrier?","volume":"13","author":"Sokolowska","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2021.102433_bb0840","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/15287394.2020.1748779","article-title":"Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models","volume":"83","author":"Kobos","year":"2020","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.nano.2021.102433_bb0845","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fimmu.2020.00818","article-title":"Exacerbation of nanoparticle-induced acute pulmonary inflammation in a mouse model of metabolic syndrome","volume":"11","author":"Alqahtani","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2021.102433_bb0850","doi-asserted-by":"crossref","first-page":"122440","DOI":"10.1016\/j.jhazmat.2020.122440","article-title":"Non-cytotoxic silver nanoparticle levels perturb human embryonic stem cell-dependent specification of the cranial placode in part via FGF signaling","volume":"393","author":"Hu","year":"2020","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.nano.2021.102433_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238977","article-title":"Early postnatal exposure to a low dose of nanoparticulate silver induces alterations in glutamate transporters in brain of immature rats","volume":"21","author":"Dabrowska-Bouta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2021.102433_bb0860","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1049\/iet-nbt.2020.0039","article-title":"Hepatic histopathological and ultrastructural alterations induced by 10 nm silver nanoparticles","volume":"14","author":"Al-Doaiss","year":"2020","journal-title":"IET Nanobiotechnol"},{"key":"10.1016\/j.nano.2021.102433_bb0865","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1038\/s41598-017-03015-1","article-title":"Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2021.102433_bb0870","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21060763","article-title":"Bioaccumulation and subchronic toxicity of 14 nm gold nanoparticles in rats","volume":"21","author":"Rambanapasi","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.nano.2021.102433_bb0875","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/17435390.2016.1264638","article-title":"Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity","volume":"11","author":"Choi","year":"2017","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2021.102433_bb0880","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12868-017-0369-9","article-title":"Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation","volume":"18","author":"Yarjanli","year":"2017","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.nano.2021.102433_bb0885","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jtemb.2016.03.017","article-title":"Are iron oxide nanoparticles safe? Current knowledge and future perspectives","volume":"38","author":"Valdiglesias","year":"2016","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.nano.2021.102433_bb0890","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/tx500333q","article-title":"Iron nanoparticles significantly affect the in vitro and in vivo expression of Id genes","volume":"28","author":"Zou","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.nano.2021.102433_bb0895","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.2147\/IJN.S135189","article-title":"Iron oxide nanoparticles and induced autophagy in human monocytes","volume":"12","author":"Wu","year":"2017","journal-title":"Int J Nanomedicine"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963421000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:16:19Z","timestamp":1761549379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963421000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":179,"alternative-id":["S1549963421000769"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2021.102433","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2021.102433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102433"}}